BOSTON, Jan. 15, 2019 /PRNewswire/ — Life Biosciences has announced the closing of a Series B financing round of $50 million, according to Tristan Edwards, chief executive officer and co-founder. The Company initially targeted a $25 million round but upsized to meet investor demand. The proceeds of the investment will be used to continue Life Biosciences’ and its Daughter Companies’ … ContinuedRead Full Article
LIFE CHANGING BREAKTHROUGHS
Aging isn’t a mystery. It can be understood and overcome.
We are the first and largest company dedicated to the research of longevity and aging in their totality. There are no fragmented solutions to a systemic breakdown.